Development Manufacture and Commercialization Sample Clauses

Development Manufacture and Commercialization. (a) GenSight shall use Diligence to develop, manufacture and commercialize (including obtaining Regulatory Approval for) the Licensed Product at its own cost and expense, either by itself or through its Sublicensees, in the Fields of Use in accordance with the development plan attached hereto as Exhibit C, which
Sample 1Sample 2
AutoNDA by SimpleDocs
Development Manufacture and Commercialization. (a) Overview. During the Term, GeoVax will be solely responsible for the Development, Manufacture, and Commercialization, including all costs thereof, of Licensed Product in the Field in the Territory.
Sample 1
Development Manufacture and Commercialization. 3.1 Development, Manufacturing and Commercialization in the Celgene Territory in the Field.
Sample 1
Development Manufacture and Commercialization. 3.1 Preclinical Development of Licensed Products by Omthera with Licensor as “General Contractor.” Omthera shall, throughout the Development Term, use Commercially Reasonable Efforts to Develop one or more Licensed Products, pursuant to an Omthera preclinical development program as contemplated by this Agreement (the “Development Program”). The current working version of the Development Program is attached to this Agreement as Schedule 2. Omthera and Licensor shall use Commercially Reasonable Efforts to collaborate, through the Joint Scientific Committee, to further detail the design of the Development Program. Omthera and Licensor agree that Licensor shall, for the duration of the Development Term, serve as the “general contractor” for the Development Program with responsibility and authority to arrange, manage and oversee all material aspects of the execution of the Development Program. The “
Sample 1
Development Manufacture and Commercialization. 3.1 As between the Parties, from and after the Closing Date, Flashpoint shall have sole control, authority, and discretion, at its sole expense, over the conduct of Programs, and research, development (including regulatory activities), manufacturing and commercialization of Compounds and Products. Without limiting the foregoing, as between the Parties, Flashpoint shall be solely responsible for and shall bear the entire cost of preparing and submitting registration dossiers for Regulatory Approval of Products, Flashpoint shall be the holder of all Regulatory Approvals for Products, Flashpoint shall own all submissions in connection therewith, and Flashpoint shall set the price for all Products.
Sample 1
Development Manufacture and Commercialization 
Sample 1Sample 2Sample 3See All (48)

Related to Development Manufacture and Commercialization

  • Development and Commercialization Subject to Sections 4.6 and 4.7, Fibrocell shall be solely responsible for the development and Commercialization of Fibrocell Products and Improved Products. Fibrocell shall be responsible for all costs incurred in connection with the Fibroblast Program except that Intrexon shall be responsible for the following: (a) costs of establishing manufacturing capabilities and facilities in connection with Intrexon’s manufacturing obligation under Section 4.6 (provided, however, that Intrexon may include an allocable portion of such costs, through depreciation and amortization, when calculating the Fully Loaded Cost of manufacturing a Fibrocell Product, to the extent such allocation, depreciation, and amortization is permitted by US GAAP, it being recognized that the majority of non-facilities scale-up costs cannot be capitalized and amortized under US GAAP); (b) costs of basic research with respect to the Intrexon Channel Technology and Intrexon Materials (i.e., platform improvements) but, for clarity, excluding research described in Section 4.7 or research requested by the JSC for the development of a Fibrocell Product or an Improved Product (which research costs shall be reimbursed by Fibrocell); (c) [*****]; and (d) costs of filing, prosecution and maintenance of Intrexon Patents. The costs encompassed within subsection (a) above shall include the scale-up of Intrexon Materials and related active pharmaceutical ingredients for clinical trials and Commercialization of Fibrocell Products undertaken pursuant to Section 4.6, which shall be at Intrexon’s cost whether it elects to conduct such efforts internally or through Third Party contractors retained by either Intrexon or Fibrocell (with Intrexon’s consent).

  • Commercialization Intrexon shall have the right to develop and Commercialize the Reverted Products itself or with one or more Third Parties, and shall have the right, without obligation to Fibrocell, to take any such actions in connection with such activities as Intrexon (or its designee), at its discretion, deems appropriate.

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!